AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $188,000 | -29.6% | 6,682 | -5.3% | 0.04% | -32.1% |
| Q2 2019 | $267,000 | -41.6% | 7,053 | -39.8% | 0.06% | -94.2% |
| Q1 2019 | $457,000 | +62.6% | 11,716 | -11.1% | 0.97% | +1925.0% |
| Q4 2018 | $281,000 | -41.5% | 13,184 | +8.7% | 0.05% | -4.0% |
| Q3 2018 | $480,000 | -39.6% | 12,131 | -41.7% | 0.05% | -92.9% |
| Q2 2018 | $795,000 | +1.3% | 20,810 | -20.3% | 0.70% | +3.2% |
| Q1 2018 | $785,000 | +111.0% | 26,118 | +119.5% | 0.68% | +45.8% |
| Q4 2017 | $372,000 | – | 11,898 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |